GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fate Therapeutics Inc (STU:F6T) » Definitions » Sale Of Investment

Fate Therapeutics (STU:F6T) Sale Of Investment : €305.33 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Fate Therapeutics Sale Of Investment?

Fate Therapeutics's sale of investment for the three months ended in Dec. 2024 was €58.18 Mil. It means Fate Therapeutics gained €58.18 Mil from selling investments. Fate Therapeutics's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was €305.33 Mil.

Compared with last quarter (€81.72 Mil in Sep. 2024 ), Fate Therapeutics gained less money from selling investments in Dec. 2024 (€58.18 Mil).


Fate Therapeutics Sale Of Investment Historical Data

The historical data trend for Fate Therapeutics's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fate Therapeutics Sale Of Investment Chart

Fate Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.63 614.93 573.12 437.99 315.82

Fate Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.57 95.44 70.00 81.72 58.18

Fate Therapeutics Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €305.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fate Therapeutics Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Fate Therapeutics's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Fate Therapeutics Business Description

Traded in Other Exchanges
Address
12278 Scripps Summit Drive, San Diego, CA, USA, 92131
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Fate Therapeutics Headlines

No Headlines